Inhye Ahn
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mosunetuzumab for CLL MRD Clearance (NCT07052695) | Inhye Ahn | 2025-11-24 |
| Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia (NCT06333262) | Inhye Ahn | 2024-04-22 |
| Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL (NCT04685915) | Inhye Ahn | 2021-02-18 |
Track Inhye Ahn automatically
Every clearance here is in the API, with alerts when new ones post.